Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer’s disease and healthy controls: a multicentre phase 2 diagnostic study - Barthel, H; Gertz, H-J; Dresel, SFlorbetaben Study Group (Lancet Neurol, 2011)
et al.